Showing 6651 - 6660 of 11100 for "Private equity" with applied filters
06 January 2022 by LC Lawyers
The Stock Exchange of Hong Kong Limited (“Stock Exchange”) published in December 2021 the conclusions to its consultation paper of April 2021 titled “Review of Corporate Governance Code and Related Listing Rules”, with an aim to enhance the corporate governance practices and reporting by listed companies.
04 January 2022 by LC Lawyers
In our earlier publication “COVID-19 heightened corruption risks – A Hong Kong guide”1, we forewarned that COVID-19 and the challenges it posed to enforcement authorities, organizations and their workforce would allow corruption to thrive.
24 December 2021 by Radu Tărăcilă Pădurari Retevoescu - Allen & Overy
RTPR has provided legal advice to Meridiam SAS in relation to entering Netcity Telecom’s shareholding, the company that operates the underground telecommunications infrastructure in Bucharest.
22 December 2021 by Ritch Mueller y Nicolau
We are pleased to announce the following lawyers as new partners of our firm
16 December 2021 by MLL Meyerlustenberger Lachenal Froriep
MLL is delighted to announce that Renato Bucher, Florian Müller and Christian Rebell will become partners of the firm on 1 January 2022.
14 December 2021 by Arendt & Medernach
Arendt advised 468 SPAC I SE, a Luxembourg special purpose acquisition company (SPAC) sponsored by Alexander Kudlich, former Rocket Internet board member, Ludwig Ensthaler and Florian Leibert, in its successful business combination with Boxine GmbH ("Boxine")
13 December 2021 by Nestor Nestor Diculescu Kingston Petersen
NNDKP has assisted Safety Broker, the largest independent insurance broker operating in Romania and in the Republic of Moldova, in the sale of 80% of the company’s shares to the Unilink group, leader on the relevant Polish market.
30 November 2021 by Arendt & Medernach
Stéphanie Lhomme has joined Arendt Regulatory & Consulting in the role of Director in order to strengthen Arendt’s advisory services offering to clients in the areas of Forensic Investigations, Anti-bribery & Corruption, and Corporate Intelligence.
24 November 2021 by L&L Partners
L&L Partners Law Offices advised the Carlyle Group (“Carlyle”), on setting up an integrated generic pharmaceuticals platform, known as Viyash Life Sciences Private Limited in partnership with ex-Mylan senior executive, Dr. Hari Babu Bodepudi and ex- founder of Laurus Labs, Dr. Srihari Raju Kalidindi. L&L has also advised Carlyle on all its follow-on investments into Viyash over a period of time.
24 November 2021 by L&L Partners
L&L Partners Law Offices advised the Carlyle Group on the acquisition of 100% stake of Appcure Labs Private Limited and the acquisition of majority stake in Appco Pharma LLC through its generic pharma platform, Viyash Life Sciences Private Limited.
Register for FREE and enjoy the following benefits:
IFLR1000's Ranking Analysis allows you to:
Subscribe today, simply call +44 (0)20 7779 8154 or email rvalmarana@legalmediagroup.com
IFLR1000's Ranking Analysis allows you to:
Subscribe today, simply call +44 (0)20 7779 8154 or email rvalmarana@legalmediagroup.com